Restorative Neurotechnologies: Funding, Investors & Team (Sep 2026)
Restorative Neurotechnologies is a pioneer in non-invasive neuromodulation for the rehabilitation of cognitive function. The company has completed multiple clinical studies demonstrating its digital therapy, MindLenses Professional, delivers superior clinical outcomes in domains such as attention, memory, language and executive functions compared to alternatives, in a faster therapeutic cycle. MindLenses Professional is CE-marked and a Class IIa Medical Device under European Union Medical Device Regulation (MDR) 2017/745 for post-stroke cognitive rehabilitation. The company’s technology is based on pioneering research on prismatic adaptation by founders Professor Massimiliano Oliveri at the University of Palermo, Italy, and at Harvard. Restorative Neurotechnologies' Quality Management System is certified according to ISO 13485:2016.
Restorative Neurotechnologies has raised $3.3M across 1 funding round on record, the most recent a Series A of $3.3M announced in Nov 2024.
That round is below the $4.7M median round size for Health Care companies tracked on FundedIQ over the last two years.
Restorative Neurotechnologies Company Profile and Key Stats
Latest funding round on record: Nov 2024.
Restorative Neurotechnologies Funding Rounds
Restorative Neurotechnologies Founders and Leadership Team
No contact details are on record for this team yet.
Restorative Neurotechnologies Funding Compared to Other Health Care Startups
Restorative Neurotechnologies' latest round of $3.3M is below the median round in Health Care. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Restorative Neurotechnologies in Health Care and Palermo
Companies Similar to Restorative Neurotechnologies
Niino is a digital healthcare logistics platform provide easy, rapid, and transparent access to non-urgent…
Salute360 is a digital health company committed to transforming the way patients and healthcare professionals…
Rosso is a startup in Italy focused on addressing the blood shortage crisis by connecting various…
Pharma Green Holding is a company that aims to create a unified and advanced pharmacy network that delivers…
A Start Up founded in December 2016 and committed to the discovery and development of orphan drugs for…
Antonio D'Angelo and Andrea Cazzulani discovered that a highly effective medication was struggling to become…
Approxima is a new MedTech startup in the early stages of developing a method for replacing the tricuspid…
Dentistry nutraceuticals
We apply IT to Bionics in order to Turn disabilities into New Possibilities
Soundsafe Care is a medical startup company that disrupts traditional surgical practices by combining…
ADOR develops, manufactures and markets unique in-vitro diagnostic solutions, which is specially designed for…
Restorative Neurotechnologies Funding FAQs
What does Restorative Neurotechnologies do?
Restorative Neurotechnologies is a pioneer in non-invasive neuromodulation for the rehabilitation of cognitive function. The company has completed multiple clinical studies demonstrating its digital therapy, MindLenses Professional, delivers superior clinical outcomes in domains such as attention, memory, language and executive functions compared to alternatives, in a faster therapeutic cycle. MindLenses Professional is CE-marked and a Class IIa Medical Device under European Union Medical Device Regulation (MDR) 2017/745 for post-stroke cognitive rehabilitation. The company’s technology is based on pioneering research on prismatic adaptation by founders Professor Massimiliano Oliveri at the University of Palermo, Italy, and at Harvard. Restorative Neurotechnologies' Quality Management System is certified according to ISO 13485:2016.
How much funding has Restorative Neurotechnologies raised?
Restorative Neurotechnologies has raised $3.3M across 1 round on record. The most recent is a Series A of $3.3M announced in Nov 2024.
When did Restorative Neurotechnologies last raise funding?
Restorative Neurotechnologies' most recent funding round on record is a Series A of $3.3M, announced in Nov 2024.
Who founded Restorative Neurotechnologies?
FundedIQ lists Agnese Di Garbo (Founder) at Restorative Neurotechnologies.
Where is Restorative Neurotechnologies headquartered?
Restorative Neurotechnologies is based in Palermo, Sicilia, Italy.
How many employees does Restorative Neurotechnologies have?
Restorative Neurotechnologies is in the 11-50 employee band.
How does Restorative Neurotechnologies' funding compare to other Health Care startups?
Restorative Neurotechnologies' latest round of $3.3M is below the $4.7M median round size for Health Care companies on FundedIQ across 3,653 tracked companies over the last two years.
About FundedIQ's Restorative Neurotechnologies Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Restorative Neurotechnologies is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.